Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study
PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment
230
Participants
Timeline
Start Date
April 30, 2014
Primary Completion Date
October 9, 2016
Study Completion Date
April 25, 2017
Conditions
Human African Trypanosomiasis (HAT)
Interventions
DRUG
Fexinidazole
Trial Locations (1)
Unknown
Kinshasa
All Listed Sponsors
lead
Drugs for Neglected Diseases
OTHER
NCT02169557 - Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study | Biotech Hunter | Biotech Hunter